Anti Vascular Endothelial Growth Factor Agents in Corneal Neovascularization
Corneal neovascularisation is a potentially blinding condition, an established risk factor for rejection and results in loss of immune privilege. It may occur as a normal physiologic healing response to various stimuli or as an inappropriate local tissue response to primary insult arising due to an...
Saved in:
| Main Authors: | Srivatsa Sehra, Reetika |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2011-07-01
|
| Series: | Delhi Journal of Ophthalmology |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/0972-0200.376568 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corneal melting following intrastromal injection of bevacizumab for corneal neovascularization
by: Muna Salim Al-Ruhaili, et al.
Published: (2025-05-01) -
Use of Bevacizumab in the Treatment of Corneal Neovascularization
by: Tuba Çelik, et al.
Published: (2015-01-01) -
Results of combined antiangiogenic activity on corneal neovascularization. Experimental and morphological study
by: V. R. Mamikpnyan, et al.
Published: (2014-09-01) -
Intravitreal bevacizumab for neovascular age-related macular degeneration
by: Junn R. Pajarillo, MD, et al.
Published: (2009-12-01) -
Vascular endothelial growth factor inhibitors in the treatment of ovarian cancer
by: S. V. Khokhlova
Published: (2014-08-01)